54868-5311 : Tarka 2/240 24 Hr Extended Release Tablet

Labeler: Physicians Total Care, Inc.
Product Type: Human Prescription Drug
Drug Name:  Tarka
Dosage Form: Oral Tablet, Film Coated, Extended Release
Application #: NDA020591
Rev. Date: 


Markings: 242
Shapes:  Oval
Colors:  Yellow
Size (mm): 19
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

242: (0074-3289) Tarka 2/240 24 Hr Extended Release Tablet by Physicians Total Care, Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 54868-5311-0: 30 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (54868‑5311‑0)
  • 54868-5311-1: 10 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (54868‑5311‑1)

Active Ingredients:

  • Trandolapril
  • Verapamil Hydrochloride

Dosage Strength:

  • 2 mg
  • 240 mg

Inactive Ingredients:

  • Docusate Sodium
  • Alcohol
  • Hydroxypropyl Cellulose
  • Lactose
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Polyethylene Glycol
  • Povidone
  • Water
  • Silicon Dioxide
  • Sodium Alginate
  • Sodium Stearyl Fumarate
  • Talc
  • Titanium Dioxide
  • Starch, Corn
  • Hypromelloses

Pharmaceutical Classes:

  • Angiotensin Converting Enzyme Inhibitor [EPC]
  • Angiotensin-converting Enzyme Inhibitors [MoA]
  • Calcium Channel Antagonists [MoA]
  • Calcium Channel Blocker [EPC]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 54868-5320 Tarka 4/240 24 Hr Extended Release Tablet by Physicians Total Care, Inc.
  • 54868-5548 Tarka 2/180 24 Hr Extended Release Tablet by Physicians Total Care, Inc.
  • 0074-3287 Tarka 2/180 24 Hr Extended Release Tablet by Abbvie Inc.
  • 0074-3288 Tarka 1/240 24 Hr Extended Release Tablet by Abbvie Inc.
  • 0074-3289 Tarka 2/240 24 Hr Extended Release Tablet by Abbvie Inc.
  • 0074-3290 Tarka 4/240 24 Hr Extended Release Tablet by Abbvie Inc.


Scan the QR code below to easily reference this data in the future:

NDC 54868-5311 QR Code

< Prev: 54868-5310Next: 54868-5312 >

Related Discussions:

verapamil difference between SR and ER
I am taking verapamil SR 240mg. A lot of drug plans only offer it as ER. What's the difference? ## There is no diffe... 27 replies
Verapamil Er - Capsule vs. Tablet
Pharmacy has changed my RX from a capsule to tablet (with approval from Dr.) Dosage is the same 240 and both are XR. Pha... 23 replies
Verapamil Er 240 Mg Capsule Colors
what color are the Veramil ER 24 by Watson Manufacturer? ## color of Verapamil er 240 capsules? ## The 240mg sustained r... 15 replies
verapamil differences between Ivax/Teva and Mylan
I had been taking Calan SR 240 for a number of years to control my ophthalmic migraines. My health insurance said that I... 5 replies
Verapamil 240 Er
I have been taking Verapamil 240 ER for many years. It works fairly well. But each time I went to get a 90 day supply it... 5 replies
Verapamil and fever
I've been on 120mg of verapamil for about 3 months. I take it for vestibular migraines. My neurologist doubled my do... 4 replies
verapamil 240mg Er capsules
green capsules same as 240 tablets? ## I can't verify that for you unless you tell me what the imprint is on the gre... 4 replies
Verapamil 240 Mg Er Tab
WHAT IS THIS MEDICINE FOR ## Verapamil extended release (240 mg) has been used in the treatment of hypertension, angina ... 4 replies
Verapamil Er 240 Mg Tablet
Can this tablet be split in half for 2 120 Mg doses? ## I'm discussing Verapamil 240 er. ## No, the ER stands for Ex... 4 replies
Verapamil 240 Ivax brand 73-00
I can no longer get this brand of Verapmil from any pharmacy located here in the Orlando Florida Area. My pharmacist tol... 3 replies

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA